CONSALVI, SARA
CONSALVI, SARA
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents
2017 Venditti, Giulia; Poce, Giovanna; Consalvi, Sara; Biava, Mariangela
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis
2021 Consalvi, S.; Venditti, G.; Zhu, J.; Boshoff, H. I.; Arora, K.; De Logu, A.; Ioerger, T. R.; Rubin, E. J.; Biava, M.; Poce, G.
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity
2013 Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; L., Sautebin; S., Pace; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; S., Schenone; A., Giordani; L., Di Francesco; P., Patrignani; Biava, Mariangela
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes
2021 Appetecchia, F.; Consalvi, S.; Berrino, E.; Gallorini, M.; Granese, A.; Campestre, C.; Carradori, S.; Biava, M.; Poce, G.
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis
2016 Consalvi, Sara; Poce, Giovanna; Ragno, Rino; Sabatino, Manuela; Lamotta, Concettina; Sartini, Stefania; Calderone, Vincenzo; Martelli, Alma; Ghelardini, Carla; Dicesaremannelli, Lorenzo; Biava, Mariangela
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery
2024 Guida, Michela; Tammaro, Chiara; Quaranta, Miriana; Salvucci, Benedetta; Biava, Mariangela; Poce, Giovanna; Consalvi, Sara
Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9
2023 Laajala, Mira; Kalander, Kerttu; Consalvi, Sara; Sheik Amamuddy, Olivier; Tastan Bishop, Özlem; Biava, Mariangela; Poce, Giovanna; Marjomäki, Varpu
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects
2019 Raguzzini, A; Poce, G; Consalvi, S; Toti, E; Palmacci, F; Biava, M; Peluso, I
COX inhibitors: a patent review (2011 - 2014)
2015 Consalvi, Sara; Biava, Mariangela; Poce, Giovanna
Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile
2013 Consalvi, Sara; G., Poce; Battilocchio, Claudio; Alfonso, Salvatore; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; M., Biava
Development of MmpL3 inhibitors for tuberculosis treatment
2019 Poce, Giovanna; Consalvi, Sara; Venditti, Giulia; Scarpecci, Cristina; Biava, Mariangela
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
2021 Aiello, Paola; Consalvi, Sara; Poce, Giovanna; Raguzzini, Anna; Toti, Elisabetta; Palmery, Maura; Biava, Mariangela; Bernardi, Marco; Kamale, Mohammad A.; Perry, George; Peluso, Ilaria
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
2023 Tammaro, Chiara; Guida, Michela; Appetecchia, Federico; Biava, Mariangela; Consalvi, Sara; Poce, Giovanna
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors
2014 Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Consalvi, Sara; Angela Di, Capua; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Lidia, Sautebin; Antonietta, Rossi; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Antonio, Giordani; Stefano, Persiani; Milena, Colovic; Melania, Dovizio; Paola, Patrignani; Maurizio, Anzini
Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors
2013 Consalvi, Sara; G., Poce; Alfonso, Salvatore; Battilocchio, Claudio; G. C., Porretta; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; Biava, Mariangela
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme
2012 Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Lidia, Sautebin; Antonietta, Rossi; Antonio, Giordani; Paola, Patrignani; Maurizio, Anzini
In vivo potent BM635 analogue with improved drug-like properties
2018 Poce, Giovanna; Cocozza, Martina; Alfonso, Salvatore; Consalvi, Sara; Venditti, Giulia; Fernandez-Menendez, Raquel; Bates, Robert H.; Barros Aguirre, David; Ballell, Lluis; De Logu, Alessandro; Vistoli, Giulio; Biava, Mariangela
Malaria transmission blocking compounds: a patent review
2022 Consalvi, Sara; Tammaro, Chiara; Appetecchia, Federico; Biava, Mariangela; Poce, Giovanna
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target
2016 Poce, Giovanna; Consalvi, Sara; Biava, Mariangela
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?
2019 Consalvi, Sara; Scarpecci, Cristina; Biava, Mariangela; Poce, Giovanna
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents | 2017 | Venditti, Giulia; Poce, Giovanna; Consalvi, Sara; Biava, Mariangela | |
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis | 2021 | Consalvi, S.; Venditti, G.; Zhu, J.; Boshoff, H. I.; Arora, K.; De Logu, A.; Ioerger, T. R.; Rubin, E. J.; Biava, M.; Poce, G. | |
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity | 2013 | Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; L., Sautebin; S., Pace; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; S., Schenone; A., Giordani; L., Di Francesco; P., Patrignani; Biava, Mariangela | |
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes | 2021 | Appetecchia, F.; Consalvi, S.; Berrino, E.; Gallorini, M.; Granese, A.; Campestre, C.; Carradori, S.; Biava, M.; Poce, G. | |
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis | 2016 | Consalvi, Sara; Poce, Giovanna; Ragno, Rino; Sabatino, Manuela; Lamotta, Concettina; Sartini, Stefania; Calderone, Vincenzo; Martelli, Alma; Ghelardini, Carla; Dicesaremannelli, Lorenzo; Biava, Mariangela | |
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery | 2024 | Guida, Michela; Tammaro, Chiara; Quaranta, Miriana; Salvucci, Benedetta; Biava, Mariangela; Poce, Giovanna; Consalvi, Sara | |
Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9 | 2023 | Laajala, Mira; Kalander, Kerttu; Consalvi, Sara; Sheik Amamuddy, Olivier; Tastan Bishop, Özlem; Biava, Mariangela; Poce, Giovanna; Marjomäki, Varpu | |
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects | 2019 | Raguzzini, A; Poce, G; Consalvi, S; Toti, E; Palmacci, F; Biava, M; Peluso, I | |
COX inhibitors: a patent review (2011 - 2014) | 2015 | Consalvi, Sara; Biava, Mariangela; Poce, Giovanna | |
Development of a novel class of derivatives as selective COX-2 inhibiting Nitric Oxide donors: improving the solubility and the biological profile | 2013 | Consalvi, Sara; G., Poce; Battilocchio, Claudio; Alfonso, Salvatore; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; M., Biava | |
Development of MmpL3 inhibitors for tuberculosis treatment | 2019 | Poce, Giovanna; Consalvi, Sara; Venditti, Giulia; Scarpecci, Cristina; Biava, Mariangela | |
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy | 2021 | Aiello, Paola; Consalvi, Sara; Poce, Giovanna; Raguzzini, Anna; Toti, Elisabetta; Palmery, Maura; Biava, Mariangela; Bernardi, Marco; Kamale, Mohammad A.; Perry, George; Peluso, Ilaria | |
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances | 2023 | Tammaro, Chiara; Guida, Michela; Appetecchia, Federico; Biava, Mariangela; Consalvi, Sara; Poce, Giovanna | |
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors | 2014 | Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Consalvi, Sara; Angela Di, Capua; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Lidia, Sautebin; Antonietta, Rossi; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Antonio, Giordani; Stefano, Persiani; Milena, Colovic; Melania, Dovizio; Paola, Patrignani; Maurizio, Anzini | |
Improving the solubility and the biological profile of a novel class of derivatives as selective COX-2 inhibiting nitric oxide donors | 2013 | Consalvi, Sara; G., Poce; Alfonso, Salvatore; Battilocchio, Claudio; G. C., Porretta; V., Calderone; A., Martelli; L., Testai; L., Sautebin; A., Rossi; C., Ghelardini; L., Di Cesare Mannelli; A., Giordani; P., Patrignani; M., Anzini; Biava, Mariangela | |
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme | 2012 | Biava, Mariangela; Battilocchio, Claudio; Poce, Giovanna; Alfonso, Salvatore; Porretta, Giulio Cesare; Consalvi, Sara; Vincenzo, Calderone; Alma, Martelli; Lara, Testai; Carla, Ghelardini; Lorenzo Di Cesare, Mannelli; Lidia, Sautebin; Antonietta, Rossi; Antonio, Giordani; Paola, Patrignani; Maurizio, Anzini | |
In vivo potent BM635 analogue with improved drug-like properties | 2018 | Poce, Giovanna; Cocozza, Martina; Alfonso, Salvatore; Consalvi, Sara; Venditti, Giulia; Fernandez-Menendez, Raquel; Bates, Robert H.; Barros Aguirre, David; Ballell, Lluis; De Logu, Alessandro; Vistoli, Giulio; Biava, Mariangela | |
Malaria transmission blocking compounds: a patent review | 2022 | Consalvi, Sara; Tammaro, Chiara; Appetecchia, Federico; Biava, Mariangela; Poce, Giovanna | |
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target | 2016 | Poce, Giovanna; Consalvi, Sara; Biava, Mariangela | |
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? | 2019 | Consalvi, Sara; Scarpecci, Cristina; Biava, Mariangela; Poce, Giovanna |